Jordan Park Group’s Pfizer PFE Stock Holding History

Jordan Park Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,268	Closed	-$245K	–	99
2021 Q2	$245K	Sell	6,268 -4,611	-42%	-$179K	0.01%	99
2021 Q1	$394K	Buy	+10,879	New	+$386K	0.02%	51

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Jordan Park Group's PFE Position: Q3 2021 in Review

Jordan Park Group sold out of Pfizer (PFE) in Q3 2021, closing a stake of 6,268 shares — an estimated $245K sold.

Jordan Park Group first reported a position in PFE in Q1 2021 and held it in 2 quarters. The position peaked at $394K in Q1 2021. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

Jordan Park Group reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
Jordan Park Group sold 6,268 Pfizer shares in Q3 2021, an estimated $245K.
Jordan Park Group first reported a position in Pfizer in Q1 2021 and held it in 2 quarters.
Jordan Park Group's Pfizer position peaked at $394K in Q1 2021.
2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Jordan Park Group's 13F filing for Q3 2021, filed 19 Oct 2021.